A look at why first prescriptions for HIV medications aren’t picked up, how a novel treatment for spinal muscular atrophy lowers healthcare utilization and disparities in multiple myeloma care were among the platinum and gold award-winning posters presented at AMCP 2024, in New Orleans.
Zolgensma Administration Lowers Healthcare Utilization
The gene therapy onasemnogene abeparvovec-xioi (Zolgensma, Novartis), while costly, can prevent or reduce symptoms associated with spinal